References
- NseirSGraillesGSoury-LavergneAMinacoriFAlvesIDurocherAAccuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admissionClin Microbiol Infect201016790290819694760
- Chinese Society of Respiratory Disease AssociationHospital-acquired pneumonia diagnosis and treatment guidelinesModern Practical Medicine200214160161
- American thoracic societyInfectious Diseases Society of AmericaGuidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumoniaAm J Respir Crit Med20051714388416
- LiJSongXYangTA systematic review of antibiotic prescription associated with upper respiratory tract infections in ChinaMedicine (Baltimore)20169519e358727175658
- ZhouYFShiWPharmacokinetic/pharmacodynamic correlation of cefquinome against experimental catheter-associated biofilm infection due to Staphylococcus aureusFront Microbiol20166151326779167
- LeeLSKiinzig-SchippersMNafzigerANComparison of 30 min and 3 h infusion regimens for imipenem/cilastatin and meropenem evaluated by Monte Carlo SimulationDiagn Microbiol Infect Dis201068325125820851549
- LüYYanZWangDHDongWLYangYXiaRTreatment study of hospital acquired pneumonia by optimizing dosing regimen of piperacillin/tazobactam:prolonged versus. regular infusionZhonghua Wei Zhong Bing Ji Jiu Yi Xue2013258479483 Chinese24021044
- LanganKMJacobJLiJPharmacokinetics of short versus extended infusion meropenem dosing in critically ill patients: a pilot studyCrit Care Resusc201416319019625161021
- LeeGCLiouHYeeRQuanCFNeldnerKOutcomes of extended-nfusion piperacillin-tazobactam: a retrospective analysis of critically ill patientsClin Ther201234122297230023195962
- LodiseTPJrLomaestroBDrusanoGLPiperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategyClin Infect Dis200744335736317205441
- Cotrina-LuqueJGil-NavarroMVAcosta-GarcíaHContinuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosaInt J Clin Pharm2016381707926474861
- Abdul-AzizMHLipmanJAkovaMDALI Study GroupIs prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohortJ Antimicrob Chemother201671119620726433783
- Peres BotaDMelotCLopes FerreiraFNguyen BaVVincentJLThe multiple organ dysfunction score (MODS) versus the sequential organ failure assessment (SOFA) score in outcome predictionIntensive Care Med200228111619162412415450